GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-cov mpro in complex with an inhibitor I2

Analyse Crystal structure of SARS-cov mpro in complex with an inhibitor I2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2D2D
Type
protein
Length
603 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.24.-
UniProt
P59641
Ligands
ENB
Pockets
6 · best druggability 0.76

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.24.-)protein30125% helix, 28% strandP59641
B3C-like proteinase (EC 3.4.24.-)protein30226% helix, 30% strandP59641

Ligands and binding sites

  • ENB · Ethyl (2E,4S)-4-[((2R)-2-{[N-(tert-butoxycarbonyl)-L-valyl]amino}-2-phenylethanoyl)amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110360.760.7991empty
25250.600.7471empty
31790.510.7826ENB
41820.450.7428ENB
5960.410.7724empty

Interfaces

1 interface between chains.

  • A–B · 1265 Ų buried · 29 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 2D2D · Crystal Structure Of SARS-CoV Mpro in Complex with an Inhibitor I2 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.